Abstract
Comparative analysis of the diagnostic accuracy of FDG PET, single-voxel, and multi-voxel
proton MRS for differentiation between radiation-induced necrosis and tumor recurrence
was done in 9 patients with brain metastases treated by gamma knife radiosurgery.
In all cases enlargement of the lesion and increase of the perilesional edema were
demonstrated by MRI on average 10.6 ± 2.6 months after initial treatment. Radiation-induced
necrosis was identified in 5 patients (histologically in 2, clinically in 3). In one
of these a false positive result of FDG PET was observed, whereas data of proton MRS
were always correct. The diagnosis of tumor recurrence was established in 4 patients
(histologically in 3, clinically in 1). Among these both FDG PET and single-voxel
proton MRS showed false negative results (each method twice), whereas multi-voxel
proton MRS always permitted us to establish the correct diagnosis. The present study
demonstrates the higher diagnostic accuracy of multi-voxel proton MRS, in comparison
with single-voxel proton MRS and FDG PET, for the differentiation of the radiation-induced
necrosis and tumor recurrence. Its use is especially important in mixed lesions with
co-existence of both post-irradiation changes and viable neoplasm. Monitoring of the
treatment response by serial multi-voxel proton MRS seems to be reasonable during
follow-up of patients with brain metastases after radiosurgery.
Key words
Gamma knife radiosurgery - radiation necrosis - tumor recurrence - proton MRS
References
1
Chin L S, Ma L, DiBiase S.
Radiation necrosis following gamma knife surgery: a case-controlled comparison of
treatment parameters and long-term clinical follow-up.
J Neurosurg.
2001;
94
899-904
2
Kimura T, Sako K, Tohyama Y, Aizawa S, Yoshida H, Aburano T, Tanaka K, Tanaka T.
Diagnosis and treatment of progressive space-occupying radiation necrosis following
stereotactic radiosurgery for brain metastases: value of proton magnetic resonance
spectroscopy.
Acta Neurochir (Wien).
2003;
145
557-564
3
Kamada K, Houkin K, Abe H, Sawamura Y, Kashiwaba T.
Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic
resonance spectroscopy.
Neurol Med Chir (Tokyo).
1997;
37
250-256
4
Ricci P E, Pitt A, Keller P l, Coons S W, Heiserman J E.
Effect of voxel position on single-voxel MR spectroscopy findings.
AJNR Am J Neuroradiol.
2000;
21
367-374
5
Chao S T, Suh J H, Raja S, Lee S Y, Barnett G.
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor
from radionecrosis in patients treated with stereotactic radiosurgery.
Int J Cancer.
2001;
96
191-197
6
Ross D A, Sandler H M, Balter J M, Hayman J A, Archer P G, Auer D L.
Imaging changes after stereotactic radiosurgery of primary and secondary malignant
brain tumors.
J Neuro-Oncol.
2002;
56
175-181
7
Rock J P, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher J L, Rosenblum M L,
Mikkelsen T.
Correlations between magnetic resonance spectroscopy and image-guided histopathology,
with special attention to radiation necrosis.
Neurosurgery.
2002;
51
912-920
8
Langleben D D, Segall G M.
PET in differentiation of recurrent brain tumor from radiation injury.
J Nucl Med.
2000;
41
1861-1867
9
Schlemmer H-P, Bachert P, Henze M, Buslei R, Herfarth K K, Debus J, Kaick G van.
Differentiation of radiation necrosis from tumor progression using proton magnetic
resonance spectroscopy.
Neuroradiology.
2002;
44
216-222
10
Kamada K, Mastuo T, Tani M, Izumo T, Suzuki Y, Okimoto T, Hayashi N, Hyashi K, Shibata S.
Effects of stereotactic radiosurgery on metastatic brain tumors of various histopathologies.
Neuropathology.
2001;
21
307-314
11
Yoshino E, Ohmori Y, Imahori Y, Higuchi T, Furuya S, Naruse S, Mori T, Suzuki K, Yamaki T,
Ueda S, Tsuzuki T, Takai S.
Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron
emission tomography and 1 H-magnetic resonance spectroscopy.
Stereotact Funct Neurosurg.
1996;
66 (Suppl 1)
240-259
12
Kizu O, Naruse S, Furuya S, Morishita H, Ide M, Maeda T, Ueda S.
Application of proton chemical shift imaging in monitoring of gamma knife radiosurgery
on brain tumors.
Magn Reson Imaging.
1998;
16
197-204
13
Schlemmer H-P, Bachert P, Herfarth K K, Zuna I, Debus J, Kaick G van.
Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic
radiotherapy.
AJNR Am J Neuroradiol.
2001;
22
1316-1324
14
Traber F, Block W, Flacke S, Lamerichs R, Schuller H, Urbach H, Keller E, Schild H H.
[1 H-MR spectroscopy of brain tumors in the course of radiation therapy: use of fast
spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr.
2002;
174
33-42 (in German)
15
Rabinov J D, Lee P L, Barker F G, Louis D N, Harsh G R IV, Cosgrove G R, Chiocca E A,
Thornton A F, Loeffler J S, Henson J W, Gonzalez R G.
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation
effects: initial experience.
Radiology.
2002;
225
871-879
16
Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S,
Ohata K, Goto T, Hara M.
Methionine positron emission tomography of recurrent metastatic brain tumor and radiation
necrosis after stereotactic radiosurgery: is a differential diagnosis possible?.
J Neurosurg.
2003;
98
1056-1064
17
Weber M A, Lichy M P, Thilmann C, Gunther M, Bachert P, Maudsley A A, Delorme S, Schad L R,
Debus J, Schlemmer H P.
[Monitoring of irradiated brain metastases using MR perfusion imaging and 1 H MR spectroscopy].
Radiologe.
2003;
43
388-395 (in German)
18
Rock J P, Scarpace L, Hearshen D, Gutierrez J, Fisher J L, Rosenblum M, Mikkelsen T.
Associations among magnetic resonance spectroscopy, apparent diffusion coefficients,
and image-guided histopathology with special attention to radiation necrosis.
Neurosurgery.
2004;
54
1111-1119
19
Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T, Tanaka T, Arai H, Nakada T.
Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery
by proton magnetic resonance spectroscopy, 2O1 TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic
resonance imaging.
J Neurosurg.
2004;
100
835-841
20
Lee P L, Gonzalez R G.
Magnetic resonance spectroscopy of brain tumors.
Curr Opin Oncol.
2000;
12
199-204
21
Chernov M F, Hayashi M, Izawa M, Abe K, Usukura M, Ono Y, Kubo O, Hori T.
Early metabolic changes in metastatic brain tumors after gamma knife radiosurgery:
1 H-MRS study.
Brain Tumor Pathol.
2004;
21
63-67
Mikhail Chernov, M. D.
Department of Neurosurgery, Neurological Institute · Tokyo Women's Medical University
8-1 Kawada-cho
Shinjuku-ku
Tokyo 162-8666
Japan ·
Phone: +81-3-3353-8111 (ext. 26216)
Fax: +81-3-5269-7438
Email: m_chernov@yahoo.com